YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
OTC: YIHCF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Juncai Jiang
- Employees
- 4,618
- Headquarters
- Yichang, China
- IPO year
- 2021
- Market cap
- $643.1M
- Website
- https://cj.hec.cn
Loading YIHCF…
Loading profile data…Frequently asked questions about YIHCF
What does YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (YIHCF) do?
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is a Chinese pharmaceutical enterprise primarily engaged in the development, manufacturing, and distribution of medicinal products. Operating within the People's Republic of China, its therapeutic expertise spans antiviral treatments, solutions for endocrine and metabolic disorders, and cardiovascu...
Where does YIHCF trade?
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (YIHCF) trades on the Other OTC.
What sector is YIHCF in?
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (YIHCF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of YiChang HEC ChangJiang Pharmaceutical Co., Ltd.?
Juncai Jiang is the chief executive officer of YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (YIHCF).
Where is YiChang HEC ChangJiang Pharmaceutical Co., Ltd. headquartered?
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is headquartered in China.
Does YIHCF pay a dividend?
Yes — YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (YIHCF) paid a trailing twelve-month dividend of USD 0.19 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did YIHCF go public?
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (YIHCF) completed its initial public offering in 2021.